Key Facts
• Marubeni President Masayuki Omoto aims to double market cap to $100 billion by FY2031.
• Plans to increase Middle East and Africa profits by 25% to $1.7 billion by FY2028.
• Focus areas include U.S. agriculture, auto sales, and renewable energy services.
• Africa’s pharmaceutical market expected to grow 10% annually; Marubeni invests in Mauritius-based Phillips Healthcare.
• Warren Buffett’s investment firm holds shares in Marubeni, highlighting its diversified business model.
• Omoto emphasizes “winning strategies” by prioritizing growth, value addition, and scalability.
• Marubeni’s U.S. operations remain its top revenue generator despite global economic uncertainties.
• Omoto, 55, became president in April 2025, succeeding Masumi Kakigi, who elevated market cap from $10 billion to $35 billion.
Summary
Marubeni Corporation’s President Masayuki Omoto has set an ambitious goal to double the company’s market capitalization to $100 billion by FY2031. Key strategies include strengthening operations in the U.S. and Africa, with a focus on agriculture, auto sales, and renewable energy. The company plans to boost Middle East and Africa profits by 25% to $1.7 billion by FY2028, supported by investments like its stake in Mauritius-based Phillips Healthcare, targeting Africa’s growing pharmaceutical market. Omoto emphasizes “winning strategies” that prioritize growth, value addition, and scalability. Notably, Warren Buffett’s investment firm holds shares in Marubeni, underscoring confidence in its diversified business model. Omoto, who became president in April 2025, aims to build on the foundation laid by his predecessor, Masumi Kakigi, who significantly increased the company’s market cap. Despite global challenges, Marubeni’s U.S. operations remain its top revenue source, with Omoto focusing on long-term sustainability and strategic growth.
